FANJ
GILD icon

Financial Architects (New Jersey)’s Gilead Sciences GILD Stock Holding History

Financial Architects (New Jersey)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,500
Closed -$102K – 1551
2017
Q1 		$102K Buy
+1,500
New +$105K 0.02% 472
2014
Q4 		– Sell
-300
Closed -$3K – 984
2014
Q3 		$3K Buy
+300
New +$29.4K ﹤0.01% 799

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Architects (New Jersey)'s GILD Position: Q2 2023 in Review

Financial Architects (New Jersey) increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2023, buying an estimated $3.03K and bringing the position to 2,794 shares worth $215K. The position accounts for 0.03% of the portfolio, ranked #304.

Financial Architects (New Jersey) first reported a position in GILD in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.02M in Q3 2016. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Financial Architects (New Jersey) held 2,794 shares of Gilead Sciences worth $215K as of Q2 2023.
  • Financial Architects (New Jersey) bought 38 Gilead Sciences shares in Q2 2023, an estimated $3.03K.
  • Gilead Sciences made up 0.03% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #304 holding.
  • Financial Architects (New Jersey) first reported a position in Gilead Sciences in Q2 2013 and has held it in 38 quarters since.
  • Financial Architects (New Jersey)'s Gilead Sciences position peaked at $1.02M in Q3 2016.
  • 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.